VI Technologies' Unattributed VC Round

VI Technologies raised a round of funding on August 15, 2001. Investors include Ampersand Capital Partners.

Vitex is developing products designed to improve the safety of the world's blood supply. The Company's proprietary INACTINE technology, currently in a Phase III clinical trial, is designed to inactiva…

Articles about VI Technologies' Unattributed VC Round: